Sign inJoin waitlistJoin the waitlist

Max Jan

Faculty, Mass General Cancer Center and Department of Pathology · Mass General Hospital

Credentials: · · · · ·

History

Mass General Hospital
2021–Present

Dana-Farber Cancer Institute
2021–2022
Massachusetts General Hospital
2020–2021
Molecular Genetic Pathology
Brigham and Women's Hospital
2018–2019
Pathology
Massachusetts General Hospital
2015–2018
University of California, San Francisco School of Medicine
2011–2015
Stanford University
2014–2015
Stanford University
2008–2011

Research

Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma
Cell · 2010 · 943 citations
Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia
Science Translational Medicine · 2012 · First of 7 authors · 615 citations
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K
Nature · 2020 · 367 citations

Ben Ebert
13 papers
Marcela Maus
10 papers
Mark Leick
8 papers
AS
Adam Sperling
5 papers
Ravi Majeti
5 papers
Ash Alizadeh
3 papers · 1 as a fellow
Bryan Choi
3 papers · 1 as a fellow
Catherine Wu
3 papers
MC
Mark Chao
3 papers · 2 as a resident
Quinlan Sievers
3 papers · 3 as a resident
Caron Jacobsen
2 papers
Chad Tang
2 papers

Grants

PROTECT - Harnessing Protein Degradation for Advancing Childhood Tumors
National Cancer Institute · OT2
Contact PI · $331.9K · Massachusetts General Hospital
2024–2026
Reprogramming the Chimeric Antigen Receptor T Cell Epigenome to Augment Anti-Tumor Activity
National Cancer Institute · K08
Contact PI · $951.1K · Massachusetts General Hospital
2021–2026